KB-R7785 is a novel ADAM12 and MMP inhibitor, ameliorating cardiac function in a transverse aortic constriction (TAC) model by inhibiting the proteolytic activation of HB-EGF signaling, exerting its antidiabetic effect by ameliorating insulin sensitivity through the inhibition of TNF-alpha production.
Molecular Weight:
349.42
CAS Number:
[168158-16-5]
Formula:
C18H27N3O4
Target:
Others|||MMP
T70280
* VAT and and shipping costs not included. Errors and price changes excepted
